Treatment Registry
TR-1065 ActiveRecorded October 2026

Compounded semaglutide

Sold by Intimate Rose · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.

Visit Intimate Rose

We earn nothing from this link. It opens Intimate Rose's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

Sourcing and terms

PharmacyNot disclosed
StatesNot disclosed
PrescriberNot disclosed
CancellationThe prescription-service policy requires cancellation at least 72 hours before renewal to avoid the next charge. Consent says the first month is charged when intake is completed. Refunds are restricted after intake submission, shipment or processed renewal, except medical disqualification; billing errors and delayed shipment are limited review cases, while damaged medication can be replaced. Prepaid unused months are refundable for medical disqualification, not a general right to refund after care begins. Product-return rules for nonprescription goods do not apply to this treatment. https://www.intimaterose.com/pages/return-policy https://www.intimaterose.com/pages/menopause-weight-loss-consent
MembershipNone. “No Memberships.”
Consult feeIncluded in program price; itemized amount is not published. The monthly-price explanation includes personalized medical oversight and provider review, with support and check-ins at no extra charge; an itemized consultation amount is not published. https://www.intimaterose.com/pages/weight-loss-treatment-online

Recorded from intimaterose.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. October 2026 — Intimate Rose lists compounded semaglutide and compounded tirzepatide as provider-selected treatment options. It publishes one shared starting program price of $169/month rather than separate confirmed prices for each ingredient or dose. Medication, free delivery, personalized medical oversight and ongoing support are listed as included. The dose, selected formulation, initial invoice and renewal amount for this specific program are not established by that starting headline. https://www.intimaterose.com/pages/weight-loss-treatment-online
  2. 2. October 2026 — The administration FAQ discusses both oral treatment and weekly injections, without assigning a route or device to either named program. The dispensed dosage form for this program is not established by the public offer. https://www.intimaterose.com/pages/weight-loss-treatment-online
  3. 3. October 2026 — Intimate Rose arranges access to medical services supplied by OpenLoop Health providers and medication from licensed compounding pharmacies; it does not itself practice medicine or dispense medication. OpenLoop's terms list Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx as network partners, with fulfillment dependent on program and location. No individual pharmacy is assigned to this program. https://www.intimaterose.com/pages/weight-loss-treatment-online https://openloophealth.com/terms-of-use
  4. 4. October 2026 — The page advertises no separate membership and flexible treatment, while consent describes a recurring subscription beginning at intake completion. The absence of a separate membership fee does not mean no renewal billing. The program is cash-pay and advertised as HSA/FSA eligible; member reimbursement is not guaranteed. https://www.intimaterose.com/pages/weight-loss-treatment-online https://www.intimaterose.com/pages/menopause-weight-loss-consent
  5. 5. October 2026 — A licensed clinician reviews the health profile before prescribing. The consent's general subscription FAQ mentions both live consultations and electronic form submissions, without identifying a mandatory visit modality for this program. State-specific patient-rights notices are not an affirmative treatment availability roster. https://www.intimaterose.com/pages/menopause-weight-loss-consent

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-1065
Medication category
compounded semaglutide
Readings
1

Related records

Cite this entry

Treatment Registry. (2026). Intimate Rose — compounded semaglutide (TR-1065). Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-1065

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.